Your browser doesn't support javascript.
loading
KDR genetic predictor of toxicities induced by sorafenib and regorafenib.
Quintanilha, Julia C F; Geyer, Susan; Etheridge, Amy S; Racioppi, Alessandro; Hammond, Kelli; Crona, Daniel J; Peña, Carol E; Jacobson, Sawyer B; Marmorino, Federica; Rossini, Daniele; Cremolini, Chiara; Sanoff, Hanna K; Abou-Alfa, Ghassan K; Innocenti, Federico.
Afiliação
  • Quintanilha JCF; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. juquint@email.unc.edu.
  • Geyer S; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN, USA.
  • Etheridge AS; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Racioppi A; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Hammond K; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Crona DJ; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Peña CE; Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA.
  • Jacobson SB; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN, USA.
  • Marmorino F; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Rossini D; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Cremolini C; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Sanoff HK; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Abou-Alfa GK; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Innocenti F; Unit of Medical Oncology 2, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
Pharmacogenomics J ; 22(5-6): 251-257, 2022 12.
Article em En | MEDLINE | ID: mdl-35484400

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Pharmacogenomics J Assunto da revista: BIOLOGIA MOLECULAR / FARMACOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Neoplasias Tipo de estudo: Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Pharmacogenomics J Assunto da revista: BIOLOGIA MOLECULAR / FARMACOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos